Non-Invasive Blood Test Cross-Validation Study


The study considers a cross-validation approach to determine the effectiveness of a non-invasive comprehensive metabolic panel (NICMP), relative to the venipuncture method. The NICMP machine learned powered device utilizes a light sensor to capture readings from either palm. The study (n=90) proves an agreement and strong correlation with respect to the NICMP and venipuncture blood draw.

Full Title of Study: “Remote Sensing Comprehensive Metabolic Panel”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Factorial Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: September 11, 2018


  • Device: Non-Invasive Comprehensive Metabolic Panel
    • The device utilizes spectroscopy and machine learning to detect metabolic analyte concentrations.

Arms, Groups and Cohorts

  • Experimental: NICMP Spectral Reading
    • Non-invasive spectral data is collected from this arm to function as the intervention of interest.
  • Active Comparator: Venipuncture CMP
    • A standard CMP blood draw is performed to function as the “gold standard” reference value. Specifically, the outcome of the experimental arm is cross-validated against the active comparator arm to determine the NICMP accuracy, relative to the venipuncture method.

Clinical Trial Outcome Measures

Primary Measures

  • Performance of Non-Invasive Comprehensive Metabolic Panel
    • Time Frame: 2-minutes
    • Determine the effectiveness, in terms of accuracy, of the NICMP against the venipuncture CMP (i.e. reference value).

Participating in This Clinical Trial

Inclusion Criteria

  • Undiagnosed population

Exclusion Criteria

  • Diagnosed population, pregnant women, mental heath/disabled, prisoners, fetus or deceased

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Joseph Allen Jr.
  • Collaborator
    • University of North Dakota
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Joseph Allen Jr., Chief Executive Officer/Biomedical Engineer – Concord Medical Technology Corporation

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.